Pharmacokinetic differences versus cyclophosphamide

John details slower activation, volume distribution differences, and implications for dosing and toxicity.

Play episode from 03:33

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!